Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
  • Eye health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • KABP® Intensive G.I
  • KABP® Urinary Tract Support
  • KABP® Mature Immune Defense®
  • KABP® DENTALAC
  • LipiGO®
  • KABP® Digest
  • Brain (DR7)®
  • DR7
  • KABP® DENTISANI
  • KABP® Baby Colic
  • KABP® Vaginal Health Balance
  • KABP Cardio
  • KABP®-051
  • AB-Protears®
  • Kaneka Probiotics L.sakei proBio65 ®
  • KABP 21®
  • KABP® MENOPAUSE
Products to Clinical Evidence (mobile)
  • Eficacia y seguridad del probiótico AB21 en niños con infecciones respiratorias comunes de origen vírico

    2024

    Espadaler Mazo et al.

    Read
  • Probiotic blend of L. plantarum and P. acidilactici (AB21) stimulates type-I interferon response in phagocytes with the participation of the IRF7 transcription factor, possibly involving both MyD88- dependent and independent mechanisms

    2024

    Altadill, T et al.

    Read
  • Probiotic effect on SARS-CoV2 immunity is associated to type-1 interferons: A post-hoc analysis of a randomized, placebo-controlled trial

    2022

    Gutierrez-Castrellon, et al

    Read
  • Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial

    2022

    Gutiérrez-Castrellón, et al

    Read
  • Using probiotics to flatten the curve of coronavirus disease COVID-2019

    2020

    Baud D, et al

    Read